Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial.

Jørgensen, Nicolai Grønne; Ahmad, Shamaila Munir; Abildgaard, Niels; Straten, Per Thor; Svane, Inge Marie; Andersen, Mads Hald; Knudsen, Lene Meldgaard

Jørgensen, Nicolai Grønne; Ahmad, Shamaila Munir; Abildgaard, Niels; Straten, Per Thor; Svane, Inge Marie; Andersen, Mads Hald; Knudsen, Lene Meldgaard.

Afiliação

Jørgensen NG; Center for Cancer Immunotherapy (CCIT), Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.
Ahmad SM; Center for Cancer Immunotherapy (CCIT), Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.
Abildgaard N; Department of Hematology, University Hospital Odense, Odense, Denmark.
Straten PT; Center for Cancer Immunotherapy (CCIT), Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.
Svane IM; Center for Cancer Immunotherapy (CCIT), Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark;; Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark.
Andersen MH; Center for Cancer Immunotherapy (CCIT), Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.
Knudsen LM; Department of Hematology, Herlev and Gentofte Hospital, Herlev, Denmark.

Stem Cell Investig ; 3: 95, 2016.

Article em En | MEDLINE | ID: mdl-28078275

Palavras-chave

B-cell lymphoma-2 (Bcl-2); myeloma; peptide; vaccination

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Stem Cell Investig Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google